SCHEMBL2548429

SCHEMBL2548429

O=C1CSC(=S)N1OS(=O)(=O)Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 5/20 0.42
▸ GSK3B P49841 5/20 0.42
▸ MEN1 O00255 11/20 0.41
▸ KMT2A Q03164 11/20 0.41
▸ GAA P10253 9/20 0.41
▸ POLB P06746 3/20 0.41
▸ L3MBTL1 Q9Y468 4/20 0.37
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ RECQL P46063 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ ALPL P05186 1/20 0.37
▸ ALPI P09923 1/20 0.37
▸ ALPG P10696 1/20 0.37
▸ PLCG1 P19174 1/20 0.37
▸ CASP6 P55212 1/20 0.37
▸ THRB P10828 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37707 0.72 GSK3A (0.48) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL9310226 0.72 VDR (0.52) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL8388898 0.71 GSK3A (0.40) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL16098883 0.71 GSK3A (0.47) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL3027543 0.68 GSK3A (0.44) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL25573 0.67 GSK3A (0.47) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL1194880 0.67 GSK3A (0.47) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL12333650 0.67 GSK3A (0.47) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL2148466 0.66 MAPT (0.44) GSK3AGSK3BMEN1KMT2AGAA
SCHEMBL8580463 0.66 KMT2A (0.46) GSK3AGSK3BMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11618825-B2 Rhodamine dyes and conjugates PHARMACOPHOTONICS, INC. (US) 2023-04-04 — — US disclosed
US-20210403719-A1 RHODAMINE DYES AND CONJUGATES PHARMACOPHOTONICS INC D/B/A FAST DIAGNOSTICS (US) 2021-12-30 — — US disclosed
US-11130865-B2 Rhodamine dyes and conjugates PHARMACOPHOTONICS, INC. (US) 2021-09-28 — — US disclosed
US-20200109289-A1 NOVEL RHODAMINE DYES AND CONJUGATES PHARMACOPHOTONICS, INC. D/B/A FAST BIOMEDICAL (US) 2020-04-09 — — US disclosed
CN-109456341-A Sulfonamide rhodamine compounds with alkynyl or azido derivative sites, and preparation method and application thereof 大连理工大学 2019-03-12 — — CN disclosed
US-20190016896-A1 NOVEL RHODAMINE DYES AND CONJUGATES PHARMACOPHOTONICS, INC. D/B/A FAST DIAGNOSTICS 2019-01-17 — — US disclosed
US-9938410-B2 Rhodamine dyes and conjugates PHARMACOPHOTONICS, INC. (US) 2018-04-10 — — US disclosed
US-20160208101-A1 NOVEL RHODAMINE DYES AND CONJUGATES PHARMACOPHOTONICS, INC. D/B/A FAST DIAGNOSTICS 2016-07-21 — — US disclosed
US-9169398-B2 Rhodamine dyes and conjugates PHARMACOPHOTONICS, INC. (US) 2015-10-27 — — US disclosed
US-20140256946-A1 NOVEL RHODAMINE DYES AND CONJUGATES PHARMACOPHOTONICS, INC. D/B/A FAST DIAGNOSTICS (US) 2014-09-11 — — US disclosed
US-8809531-B2 Rhodamine dyes and conjugates PHARMACOPHOTONICS, INC. (US) 2014-08-19 — — US disclosed
US-20130096309-A1 NOVEL RHODAMINE DYES AND CONJUGATES PHARMACOPHOTONICS, INC. D/B/A FAST DIAGNOSTICS 2013-04-18 — — US disclosed
EP-2552492-A2 SINGLE ISOMERIC CONJUGATES OF RHODAMINE DYES Pharmacophotonics, Inc. (US) 2013-02-06 — — EP disclosed
WO-2011123820-A2 NOVEL RHODAMINE DYES AND CONJUGATES PHARMACOPHOTONICS, INC. (US) 2011-10-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210403719-A1 RHODAMINE DYES AND CONJUGATES RCN1, RDX, CIT GSK3A 4784/4885GSK3B 4753/4885MEN1 1824/4885
US-20190016896-A1 NOVEL RHODAMINE DYES AND CONJUGATES RDX, CIT, RCN1 GSK3A 4767/4885GSK3B 4727/4885MEN1 2307/4885
US-11618825-B2 Rhodamine dyes and conjugates RCN1, RDX, CIT GSK3A 4784/4885GSK3B 4753/4885MEN1 1824/4885
US-11130865-B2 Rhodamine dyes and conjugates RCN1, RDX, CIT GSK3A 4784/4885GSK3B 4753/4885MEN1 1824/4885
US-20200109289-A1 NOVEL RHODAMINE DYES AND CONJUGATES RDX, CIT, RCN1 GSK3A 4767/4885GSK3B 4727/4885MEN1 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback